ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has appointed Stella Panu as non-executive director.
With over 20 years’ experience in corporate finance and investment management, Stella’s expertise will support the ValiRx Board and senior management team to unlock investment potential and accelerate and manage business growth for the company.
In her role, she will also oversee ValiRx’s M&A activity, advising on corporate structure and governance, risk management, and shareholders’ rights.